Navigation Links
Transgenomic Reports Third Quarter Financial Results
Date:11/15/2010

same period of 2009, which included income from foreign currency revaluation of $0.1 million.  

The net loss for the third quarter of 2010 was $898,000 or $0.02 per share, compared with a net loss of $366,000 or $0.01 per share for the third quarter of 2009.

Cash and cash equivalents were $4.6 million as of September 30, 2010, compared with $5.6 million as of December 31, 2009.  Subsequent to the end of the quarter the Company was awarded a series of grants in the amount of $1,070,453 from the U.S. government under the Patient Protection and Affordable Care Act.

Comment and OutlookCraig Tuttle, president and chief executive officer of Transgenomic, said, "We made enormous strides in moving our proprietary technologies forward during the third quarter, while at the same time taking measures to align our physical footprint to better match our business operations.  However, we did have some disappointments during the quarter, particularly with instrument sales.

"Personalized medicine continues to be the watchword for Transgenomic, and subsequent to the end of the quarter we announced an exciting breakthrough with our COLD-PCR technology.  Along with Dana Farber Cancer Institute and a pharmaceutical partner, we completed a development study of several new assays to detect genetic mutations in the Epidermal Growth Factor Receptor (EGFR) gene, bringing us closer to ultra-high sensitivity assays for the detection of low-level DNA mutations in body fluids.

"We also obtained CE-IVD designation and significantly expanded distribution of our SURVEYOR® Scan K-RAS mutation detection kit throughout most of the European Union. This designation now allows us to sell into the commercial market, rather than just for research purposes, and as such opens up a new level of potential customers.

"Our pharmacogenomics services business continued to grow during the quarter, and sales were up 28% versus the third quarter
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Transgenomic Awarded $1,070,453 From U.S. Government Under the Patient Protection and Affordable Care Act
2. Transgenomic to Hold Third Quarter Financial Results Conference Call on November 15, 2010
3. Transgenomic Develops New Assays to Detect EGFR Mutations Using COLD-PCR
4. Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services
5. Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services
6. Transgenomic Licenses IP From IntegraGen to Develop Genetic Test for Autism
7. Transgenomic Presents at 12th Annual BIO CEO & Investor Conference
8. Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit
9. Transgenomic, Inc. Reports Third Quarter 2009 Results
10. Transgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinsons Disease
11. Transgenomic, Inc. Reports Second Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... NEW YORK , Dec. 24, 2014 ... patient care in critical areas, announced the closing of an ... warrants to purchase up to an aggregate 3,500,000 shares of ... and $.01 per warrant.  The warrants have a per share ...
(Date:12/24/2014)... 2014   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade hypothermic storage and cryopreservation freeze ... and tissues  ("BioLife" or the "Company"), today announced that it ... 4, 2015 (the "Annual Meeting"). Because the expected ...
(Date:12/24/2014)... GMO corn cases filed across the United ... process of being consolidated in a Kansas federal court for ... MIR 162 Corn Litigation, MDL No. 2591 in the U.S. ... the Syngenta GMO corn multidistrict litigation (MDL) has been handed ...
(Date:12/24/2014)... BOSTON, MA (PRWEB) December 23, 2014 ... series is designed to introduce cutting edge communication ... partners of platform upgrades. This webinar series demonstrates ... their quest to leverage web conferencing’s most innovative ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3
... and the National Center for Creative Aging ... Beautiful Minds: Finding Your Lifelong Potential , ... develop and maintain healthy, beautiful minds by incorporating key lifestyle ... diet and nutrition, physical health, mental health and social well-being. ...
... University of Oregon researchers have devised a mathematically rich ... parameters in molecular dynamic simulations. The new approach, ... the macroscopic world, is detailed in a paper appearing ... Physical Review E . The method is all about ...
... BioInformatics LLC has closed the nominations for the ... and August 31, 2011, hundreds of scientists on The ... science suppliers on the ballot to determine the recipients ... fielded via electronic survey, will be available to fill ...
Cached Biology Technology:Proactive Brain Health Critical as Americans' Life Expectancy Reaches All Time High 2Proactive Brain Health Critical as Americans' Life Expectancy Reaches All Time High 3Proactive Brain Health Critical as Americans' Life Expectancy Reaches All Time High 4Catching molecular motion at just the right time 2Catching molecular motion at just the right time 3BioInformatics LLC Announces the Nominees for the 2011 Life Science Industry Awards® 2BioInformatics LLC Announces the Nominees for the 2011 Life Science Industry Awards® 3BioInformatics LLC Announces the Nominees for the 2011 Life Science Industry Awards® 4
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform ... State of Washington,s Department of Licensing, in the ... issuance system for driver,s licenses and identification cards to its ... development will start in January 2015, with enrollment and card ...
(Date:1/22/2015)...  BellBrook Labs, a leader in high throughput screening ... a TR-FRET (time resolved Forster resonance energy transfer) ... high throughput screening assay for glycosyltransferases and other ... sensitive detection of hundreds of human and microbial ...
(Date:1/22/2015)... 21, 2015  Analyst Report Issued by Small Cap IR. In ... that planet-wide, transactions at merchants on the leading payment cards ... of credit, debit, and prepaid cards reached 6.54 billion.  Eight ... fraudulent card usage in 2012, and credit and debit card ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... have eyes that are incredibly complex others manage without. ... urchins see with their entire body despite having no eyes ... journal Proceedings of the National Academy of Sciences ... a very sophisticated way of seeing complex images so that ...
... is available in German . When ... be passed on error-free to the daughter cells. Researchers at ... using fission yeast as a model organism. In cooperation with ... additional tasks to the Aurora enzymes, which were already recognized ...
... Bethesda, MDA sizzling genetic discovery by Chinese scientists may ... into humans. Their research presented in the Journal ... major step forward toward filling the shortage of vital ... work, they showed that altering or overexpressing the human ...
Cached Biology News:New tasks attributed to Aurora proteins in cell division 2New tasks attributed to Aurora proteins in cell division 3More than bacon: Genetic alterations in pig tissue may allow for human transplantation 2
QPRT Immunogen: QPRT (NP_055113, 198 a.a. ~ 298 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
...
Antibody Diluent for IHC 125 ml...
Biology Products: